Aligned in Acceleration: An Introduction to Our Colleagues at Within3, Their Insights Management Platform and Its Potential Implications for Preclinical Testing

Our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways. Their platform improves life science teams’ engagement with key opinion leaders in asynchronous applications like advisory boards, helps teams find the right KOLs anywhere on the globe and helps teams make the most out of medical congresses…

Preclinical Implications for 3D Printed and Bioresorbable Medical Technologies

The phrase “personalized medicine” has been thrown about by so many for so long in healthcare as to defy definition: or require post graduate work in any one of dozens of specific clinical or technological fields.   For the sake of brevity, 3D printing and bioresorbable material technologies are actively realizing personalized medicine in the…

Quite a Ride! Meet the GCMI Team: Saylan Lukas, Director of Research and Development Engineering

So many engineers probably wanted to be an astronaut as kids at some point or another. Saylan Lukas wanted to design roller coasters.   Fortunately for GCMI, our clients and patients benefiting from novel medical technologies, Saylan’s elective in Biomedical Engineering taught by Dr. Sam Hulbert at Rose-Hulman Institute of Technology shifted his career course…

New Technologies for Neurosurgery, Urology and Endoscopy Earn Inaugural I3 GCMI Research Awards

“In partnership with Georgia CTSA (Clinical and Translational Science Alliance), the I3 (Imagine, Innovate, and Impact) GCMI Research Awards are intended to spark synergistic interactions among investigators from the Emory School of Medicine (SOM) with Georgia Tech affiliate the Global Center for Medical Innovation (GCMI). Proposals are envisioned to improve patient care by more effectively…

Stars Align – Stridelink quickens march to commercialization with remote monitoring capabilities, CMS CPT codes

The team’s work to date, from concept to the technology’s current state, had primed it to seize the opportunity presented by the January 2022 Centers for Medicare and Medicaid Services (CMS) announcement of five new remote therapeutic monitoring CPT codes.

Early, consistent focus on the unmet need keeps Augment Health on a solid commercialization pathway

“When your ‘north star’ is doing what’s right for the patient and the user, everything else can follow. The best way to accelerate clinical adoption and utility is to prove your early hypotheses, generate data and gather clinical input.”

The 2022 State of Medtech Design and Development Landscape

Medical technology innovation and critical supporting service providers are not only working through pent up demand for delayed projects from 2020 and 2021, but also striving to advance technologies that reduce cost and improve patient outcomes developed much more recently. The U.S. FDA is striving to support innovation with new programs and guidelines that improve…

Partner Event to Consider: Health Connect South’s 2022 Annual Gathering

Our colleagues at Health Connect South are in the final stages of preparing for their 2022 Gathering on September 22nd at the Georgia Aquarium.   “Though the Southeast is home to world-class health assets, there is surprisingly little interdisciplinary clarity around areas of focus, impact, needs and capacity within and among our health assets. We…

Orthopaedic Innovators: Do Not Underestimate the Importance of Process in “Medtech Innovation: From Unmet Clinical Needs to Clinical Solutions”

Join GCMI’s Dr. Emily Blum, Evan Goldberg, PhD and John Tipton for an ORS Innovation Network Webinar August 31, 2022   “For over 60 years, the Orthopedic Research Society (ORS) has been the leading research society supporting engineers, orthopaedic surgeons, biologists, veterinarians, and clinicians in pursuit of a world without musculoskeletal limitations.”   GCMI and…

Rooted in Cardiology: Let’s talk preclinical and cardio innovation at TCT 2022

Founded by Cardiologists In the late 1990s, Dr. Robert Matheny, Chief Scientific Officer of CorMatrix Cardiovascular Inc., was looking for accessible resources, including preclinical support, needed to support innovation in care for cardiovascular physicians and their patients.   In 1999, his collaboration with other Atlanta area interventional cardiologists and cardiothoracic surgeons resulted in the development…